Attending the Humedix Re2O Fine Launch Symposium

The doctors reviewed clinical cases and the skin regeneration principles behind Re2O Fine, an ECM booster developed for delicate areas such as the eyes and neck.

Dr. Soyoun Koo and Dr. Chang-Hwan Cho attended Humedix’s Re2O Fine launch symposium in Seoul on June 24, 2026. The event introduced the extracellular matrix (ECM) booster made with human acellular dermal matrix (hADM), covering clinical applications, treatment techniques and developments in ECM-based skin regeneration. Re2O Fine uses smaller particles than the existing product and was developed for precise treatment of thinner skin around areas such as the eyes and neck.

The discussion explored an approach that aims to improve the skin’s ECM environment and support its structure, alongside volume considerations. Presentations covered eye and neck lines, principles of ECM regeneration, practical treatment experience and current clinical findings. Particular attention was given to age-related changes in the extracellular matrix and their implications for restoring the skin environment.

Dong-An Joongsim Clinic will continue taking part in clinical education and reviewing current evidence to support safe, effective treatment and patient satisfaction.